Download presentation
Presentation is loading. Please wait.
Published byDaniel Hopkins Modified over 8 years ago
1
Jalal Jalal Shokouhi-MD Ali Akbar Ameri- MD Shahyar Pashaei-PhD, anatomist Jalaljalalshokouhi@hotmail.com www.medimage.ir +989121137884
2
Endometerium: 1. US is first choice 2. MRI: diagnosis and staging of malignancies * MR-features do not diagnose endometrial polyps from cancer!?
3
1- Benign lesions Congenital UT disorders, leiomyomas, polyp, hyperplasia, adenomyosis, endometeriosis,cystic teratomas
7
Endometrial atrophy
8
UTERINE PERISTALSIS
10
DIDELPHYS
11
BICORNUATE
12
Mimics of Bicornute Uterus
13
SEPTATE
15
COMPLEX ANOMALIES
19
2-Malignants: endometrial cancer (early, late, recurrence), sarcoma, adenosarcoma, mixed mesodermal, neoplasms, liomyosarcoma, lymphoma, choriocarcinoma, metastasis
21
ENDOMETRIAL CANCER, EARLY STAGE
22
ENDOMETRIAL THICKENING
23
ENDOMETRIAL POLYP ADENOMYOSIS
24
ENDOMETRIAL CANCER, LATE STAGE
26
ENDOMETRIAL CANCER, RECURRENCE
27
DDx: Endometrial Carcinoma Recurrence Post-surgical granuloma
29
ENDOMETRIAL CANCER, RECURRENCE
32
ENDOMETRIAL STROMAL SARCOMA
33
ADENOSARCOMA
34
Uterine masses Endometrial polyp Endometrial cancer
35
MALIGNANT MIXED MESODERMAL TUMOR
36
LYMPHOMA, UTERUS
37
Choriocarcinoma,uterus
38
DDx: Choriocarcinoma Molar pregnancy Retained products of conception
39
Metastases, uterus
54
3-Others: adenomyosis, asherman, cystic adenomyosis, tomoxifen, induced changes, IUCD, age and hormonal changes
55
ADENOMYOSIS
58
Cystic adenomyosis
59
Hemorrhagic leiomyoma Gartner duct cyst
61
INTRAUTERINE DEVICE EVALUATION
62
TAMOXIFEN-INDUCED CHANGES
63
Endometerium: 1. Proliferatine 3-8 mm 2. Secretary 5-16 mm 3. Menopause a. No bleeding = 8 mm b. With bleeding = 5 mm 4. Atrophic > 4 mm
64
MRI of endometrium: T1 intermediate signal T2 high signal STIR, MR-myelogram high signal * UT peristalsis signal ↓, thickness change
65
Conclusion: *MR-features do not accurately distinguish endometrial polyps from cancer because images limited to T2 signal and T1 anatomy *For congenital anomalies 75-100% accuracy *Can be use for diethylbestrol exposure (hyperplasia, T-shaped, UT, endometrial constriction, hydrosalpinges and short cervix)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.